Ardsley Advisory Partners LP Sesen Bio, Inc. Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$0.95 - $2.46 $19,475 - $50,430
-20,500 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$0.69 - $1.47 $14,144 - $30,135
20,500 New
20,500 $21,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email